Welcome on the Necker-Enfants Malades Institute website
Leadership
The Necker-Enfants Malades Institute is administered by one Director assisted by the two department Heads and one General secretary in charge the administration. Each PI or CoPI is responsible for his (her) scientific project and for the use of his (her) allocated space
Xavier Nassif
INEM Director
Fabiola Terzi
Director of "Growth and Signalling" Dept
Peter Van Endert
Director of "Immunology, Infectiology and Haematology" (I2H) Dept
Sophie Koutouzov
General Secretary
Research Teams
Seventeen research teams are founding members of the Necker-Enfants Malades Institute. The teams are grouped in two departments: a department of cell biology (Growth and Signalling) and a department of, Immunology, Infectiology and Haematology (I2H). The Necker-Enfants Malades Institute currently comprises 103 senior scientists, one third of whom are medical doctors, 60 technicians and engineers, 35 postdoctoral fellows and 37 PhD students.
«Cell biology (Growth and Signalling)» Department
Vincent Goffin
Prolactin and Growth Hormone Pathophysiology: Translational Approaches
Franck Oury
Hormonal regulation of brain development and functions
Mario Pende & Ganna Panasyuk
Cell growth control by nutrients
Etienne Morel
Autophagy pathway and intracellular compartments dynamics
Marco Pontoglio
Epigenetics and development
Isabelle Sermet Gaudelus
Cystic fibrosis and other epithelial respiratory protein misfolding diseases
Fabiola Terzi
Mecanisms and therapeutic strategies of chronic kidney disease
Guillaume Canaud
Precision medicine for diseases of the mTOR pathway
«Immunology, infectiology and Haematology (I2H)» Department
Laurence Arbibe
Genome plasticity and infections
Elizabeth Macintyre & Vahid Asnafi
Normal and pathological lymphoid differentiation
Lucienne Chatenoud & Maria Leite-De-Moraes
Immunoregulation and Immunopathology
Claude-Agnès Reynaud & Jean-Claude Weill
Development and activity of the immune system
Xavier Nassif & Alain Charbit
Pathogenesis of systemic infections
Peter Van Endert
Innate and adaptive immune pathways in autoimmunity and autoinflammation
Sophie Ezine & Flora Zavala
Lymphopoiesis and immunoregulatory hematopoietic progenitors
Pamela Schnupf
Host-Microbiota Interaction
Simon Fillatreau
Immunity in health and disease
Scientific Advisory Board
The Scientific Advisory Board (SAB) is composed of 7 international scientific personalities, experts in their field. Its role will be to advise the INEM on scientific orientations and the recruitment of new groups. If necessary, the SAB might be consulted for strategic decisions. The chairman of the scientific advisory board is Jules Hoffmann, Nobel Prize in Medicine 2011.
Pr. Ana Maria Cuervo
Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, New York (USA)
Pr. Jules Hoffmann
University of Strasbourg, Institute for Molecular and Cellular Biology, Strasbourg (France)
Pr. Luca Scorrano
University of Padua, Department of Biology, Padua (Italy) Venetian Institute of Molecular Medicine, Padua (Italy)
Pr. Eric Gerd Pamer
Memorial Sloan-Kettering Cancer Center, Department of Medicine, Infectious Diseases Service, New York (USA)
Pr. Dr. Gunter Hammerling
German Cancer Research Center (DKFZ), Heidelberg (Germany)
Pr. Markus Muschen
University of California San Francisco, Department of Laboratory Medicine, San Francisco (USA)
Pr. Dr. Gerd Walz
University of Freiburg, BIOSS Center for Biological Signalling Studies, Freiburg (Germany)
Administration
General Services

The administrative platform is led by the General Secretary with the assistance of the administrative and financial management. Its mission is the management of human resources, finance and movable heritage. It also coordinates the general kitchen and washroom services, prevention & safety, technology transfer and development, informatics.

Sophie Koutouzov
General Secretary
Josiane Sage-Preat
Administrative and financial Director
Address

Notice: Undefined variable: contact_addr in /homepages/40/d483507699/htdocs/location.php on line 25
Support(s)
HRH Princess Caroline of Hanover, who through the Princess Grace Foundation, already supports medical research and anything that helps to relieve the sick children in France and around the world, has agreed to commit to our side so that our Center of Molecular medicine continues to meet the current challenges and fight diseases, and in particular the ones affecting children.

Notice: Undefined index: screen_height in /homepages/40/d483507699/htdocs/index.php on line 344